Also, MeD-seq analysis demonstrated that the hypermethylation score of HOXA1, CLEC11A, and TSPYL5 was higher in non-cirrhotic HCC than benign lesions, indicating that the transition from benign lesions to non-cirrhotic HCC involves significant DNA methylation changes. The gene discussed is CLEC11A; the disease is hepatocellular carcinoma.